Marker Therapeutics (MRKR) Shares Outstanding (Entity) (2010 - 2026)
Marker Therapeutics' Shares Outstanding (Entity) came in at 16.7 million for Q2 2026, up 47.8% from 11.3 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Going back to Q2 2010, Marker Therapeutics' Shares Outstanding (Entity) data covers 65 quarters.
- Shares Outstanding (Entity) has increased in each of the last 11 years, with a five-year compound annual growth rate of 26.9% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 10.7 million in FY2024 (+20.2%), 8.9 million in FY2023 (+6.0%), 8.4 million in FY2022 (+1.1%) and 8.31 million in FY2021 (+63.9%).
- Year-over-year, Shares Outstanding (Entity) has increased for 46 consecutive quarters, with growth averaging 39.3% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.6% (Q2 2022) to 87.6% (Q3 2025).
- Business Quant data shows MRKR's Shares Outstanding (Entity) at 16.7 million (Q1 2026), 16.7 million (Q4 2025) and 16.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | 16.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.70 Mn |
| Mar 31, 2026 | 16.70 Mn |
| Dec 31, 2025 | 16.70 Mn |
| Sep 30, 2025 | 16.70 Mn |
| Jun 30, 2025 | 11.30 Mn |
| Mar 31, 2025 | 11.20 Mn |
| Dec 31, 2024 | 10.70 Mn |
| Sep 30, 2024 | 8.90 Mn |
| Jun 30, 2024 | 8.90 Mn |
| Mar 31, 2024 | 8.90 Mn |
| Dec 31, 2023 | 8.90 Mn |
| Sep 30, 2023 | 8.80 Mn |
| Jun 30, 2023 | 8.80 Mn |
| Mar 31, 2023 | 8.80 Mn |
| Dec 31, 2022 | 8.40 Mn |
| Sep 30, 2022 | 8.36 Mn |
| Jun 30, 2022 | 8.36 Mn |
| Mar 31, 2022 | 8.35 Mn |
| Dec 31, 2021 | 8.31 Mn |
| Sep 30, 2021 | 8.31 Mn |
API Access
Marker Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();